Under new ownership, Fresh & Easy launches new marketing campaign
EL SEGUNDO, Calif. — Fresh & Easy has launched new five-pillar marketing campaign inviting customers to discover an all-new Fresh & Easy since it transferred to new ownership in November.
The marketing campaign will include radio, outdoor, digital and social media elements running in all markets. The campaign is centered on five pillars that are designed to differentiate Fresh & Easy as new kind of market designed for modern consumers:
- Affordable Organics
- Handmade in our Kitchen: All of its freshly prepared food is hand-picked, hand-chopped and handmade by chefs.
- Delivered Fresh Daily
- No Hidden Unpronounceables
- Meal Solutions: Whether a shopper is looking for a quick bite or a gourmet meal, the grocer has hundreds of prepared meals available.
“Our goal with this marketing campaign is to welcome shoppers to see the new Fresh & Easy,” stated Mike Evans, Fresh & Easy’s head of marketing. “We set out to make our stores and our brand fresher, easier and more relevant to modern consumers who are looking for healthy, convenient options.”
In September, Tesco announced plans to sell the Fresh & Easy business to private investment firm, the Yucaipa Cos. Yucaipa’s acquisition of Fresh & Easy was completed in November.
New England regional summit held to address opioid abuse
NEW YORK — In an effort to address opioid drug abuse, governors of five New England states convened for a summit on Monday, the National Association of Boards of Pharmacy stated.
According to the NABP, the summit was part of Massachusetts Gov. Deval Patrick’s plan to address abuse of prescription painkillers and heroin, and included discussion of how state law enforcement agencies can better coordinate to keep illegal drugs and diverted prescription drugs from crossing state lines.
In March, Patrick declared the opioid addiction epidemic a public health emergency in Massachusetts.
FDA issues draft guidance, seeks comment on identifying illegitimate drugs in supply chain
WASHINGTON — The Food and Drug Administration has published a draft guidance document for prescription drug supply chain stakeholders as part of the agency’s implementation of the Drug Supply Chain Security Act, the National Association of Boards of Pharmacy has reported.
The draft “Guidance for Industry: Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification” provides information about identifying and reporting suspect and illegitimate prescription drug products in the supply chain.
According to the NABP, the FDA is seeking public comment on the proposal by Aug. 11. Comments received by this deadline will be considered before the agency begins work on the final guidance, notes FDA. Signs of potentially illegitimate drug products discussed in the draft include:
- Labels containing misspelled words or other deviations from standard labeling;
- Products with unusual shapes, colors, or odors compared to standard products;
- Packages missing identifying information such as the lot number or expiration date; and
- Opened, damaged, repaired, or altered packaging seals.